Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccines|March 2, 2019
Pneumococcal Vaccines: Challenges and ProspectsPaul Licciardi, Ioanna Papadatou
Journal of Visualized Experiments : Jove|May 7, 2014
Investigating the effects of probiotics on pneumococcal colonization using an in vitro adherence assayEileen M Dunne, Zheng Q Toh, Mary John, et al.
Drug Discovery Today|June 14, 2011
Chromatin modifying agents - the cutting edge of anticancer therapyFaith A A Kwa, Aneta Balcerczyk, Paul Licciardi, et al.
Journal of Immunology Research|June 24, 2015
Correlates of Protection for M Protein-Based Vaccines against Group A StreptococcusShu Ki Tsoi, Pierre R Smeesters, Hannah R C Frost, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2015
Administration of a probiotic with peanut oral immunotherapy: A randomized trialMimi L K Tang, Anne-Louise Ponsonby, Francesca Orsini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific ImmunityHannah R Frost, Delphine Laho, Martina L Sanderson-Smith, et al.
Medicine|April 29, 2018
Creation, characterization, and assignment of opsonic values for a new pneumococcal OPA calibration serum panel (Ewha QC sera panel A) for 13 serotypesRobert L Burton, Han Wool Kim, Soyoung Lee, et al.
BMJ Open|November 30, 2021
Simplified 0+1 and 1+1 pneumococcal vaccine schedules in Ho Chi Minh City, Vietnam: protocol for a randomised controlled trialBeth Temple, Hau Phuc Tran, Vo Thi Trang Dai, et al.
BMJ Open|June 10, 2018
Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trialBeth Temple, Nguyen Trong Toan, Doan Y Uyen, et al.
Vaccine: X|March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal <i>Haemophilus influenzae</i> protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
Pageof 2